FDA Inspection 1116511 — Biogenesis, Inc

Biogenesis, Inc — FEI 3004933570

The FDA completed an inspection of Biogenesis, Inc on Jan 17, 2020 in Paterson, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 17, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paterson, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.